UPC Analytics
ENDE
Overview · Filed:

UPC_APP_11261/2025

REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

OtherPreliminary ObjectionMunich LDPreliminary objection
  • 2025-04-17Procedural onlyjurisdictionalPreliminary objection

    The Local Division Munich ruled on preliminary objections filed by BioNTech and Pfizer entities challenging UPC jurisdiction over Comirnaty COVID-19 vaccine variants sold before 1 June 2023, addressing the UPC's temporal jurisdiction in relation to the opt-out regime and the date of UPC operation.